![Matt Winterman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 86 912 $ al 30/06/2026
Matt Winterman currently works at Perrigo Co. Plc, as Executive VP-Global Operations & Supply Chain from 2025.
Mr. Winterman also formerly worked at Roche Holding AG, as Head-Global Supply Chain.
Mr. Winterman received his undergraduate degree from the University of Bristol.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PERRIGO CO. PLC 0,01 % | 08/07/2026 | 8.365 ( 0,01 % ) | 86 912 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PERRIGO COMPANY PLC | Director de Operaciones | 23/06/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perrigo Co. Plc
 Perrigo Co. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
